Nikolai Petrovsky

Professor Nikolai Petrovsky is a physician and vaccine researcher. He is the founder of Vaxine, an Australian biotechnology company applying novel approaches including artificial intelligence to vaccine and adjuvant development. His research has been awarded multi-million dollar grants from the US National Institutes of Health, has authored over 250 peer-reviewed research papers and in an inventor on multiple vaccine patents. He is the developer of SpikoGen®, a vaccine against COVID-19 that received emergency use authorization in the Middle East in October 2021, making it the first adjuvanted COVID-19 spike protein vaccine to achieve regulatory approval.